Giacomo Koch
Works at
Lead investigator
Sources: openalex.org
Grants and prizes
Alzheimer's Drug Discovery Foundation
Clinical, Phase 3 trial of dopaminergic therapy in patients with Alzheimer’s disease., ADDF-21100589, 2022–2024, 1 Aug 2022
Alzheimer's Disease Research: Standard, Precuneus rTMS: a novel therapy for mild AD patients, A2019523S, 2019–2022, 1 Jul 2019
Sources: openalex.org